The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 9 October 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 324K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kedl, R. M.
Right arrow Articles by Marrack, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kedl, R. M.
Right arrow Articles by Marrack, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/10/1105/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 8, October 16, 2000 1105-1114


Original Article

T Cells Compete for Access to Antigen-bearing Antigen-presenting Cells

Ross M. Kedla,c, William A. Reesc, David A. Hildemanb, Brian Schaeferb, Tom Mitchellc, John Kapplerb,c,e,f, and Philippa Marrackb,c,d,f
a Cancer Research Institute, Denver, Colorado 80206
b Howard Hughes Medical Institute, Denver, Colorado 80206
c Department of Immunology, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado 80206
d Department of Biochemistry and Molecular Genetics, Denver, Colorado 80206
e Department of Pharmacology, Denver, Colorado 80206
f Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206

Correspondence to: Ross M. Kedl, National Jewish Medical and Research Center, 5th Floor Goodman Bldg., K512, 1400 Jackson St., Denver, CO 80206. Tel:303-398-1465 Fax:303-398-1396

These studies tested whether antigenic competition between T cells occurs. We generated CD8+ T cell responses in H-2b mice against the dominant ovalbumin epitope SIINFEKL (ova8) and subdominant epitope KRVVFDKL, using either vaccinia virus expressing ovalbumin (VV-ova) or peptide-pulsed dendritic cells. CD8+ T cell responses were visualized by major histocompatibility complex class I–peptide tetrameric molecules. Transfer of transgenic T cells with high affinity for ova8 (OT1 T cells) completely inhibited the response of host antigen-specific T cells to either antigen, demonstrating that T cells can directly compete with each other for response to antigen. OT1 cells also inhibited CD8+ T cell responses to an unrelated peptide, SIYRYGGL, providing it was presented on the same dendritic cells as ova8. These inhibitions were not due to a more rapid clearance of virus or antigen-presenting cells (APCs) by the OT1 cells. Rather, the inhibition was caused by competition for antigen and antigen-bearing cells, since it could be overcome by the injection of large numbers of antigen-pulsed dendritic cells. These results imply that common properties of T cell responses, such as epitope dominance and secondary response affinity maturation, are the result of competitive interactions between antigen-bearing APC and T cell subsets.

Key Words: T cell, competition, tetramer, antigen-presenting cell, dendritic cell


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS